PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine

BACKGROUND: Trivalent inactivated flu vaccines (TIV) are currently the best means to prevent influenza infections. However, the protection provided by TIV is partial (about 50%) and it is needed to improve the efficacy of protection. Since the respiratory tract is the main site of influenza replicat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rioux, Gervais, Mathieu, Claudia, Russell, Alexis, Bolduc, Marilène, Laliberté-Gagné, Marie-Eve, Savard, Pierre, Leclerc, Denis
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4022981/
https://ncbi.nlm.nih.gov/pubmed/24885884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-3155-12-19
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars